Chromium (VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle

Carcinogenesis

Volumn 17, Issue 7, 1996, Pages 1511-1517

  Xu, Jian ^a   Bubley, Glenn J ^b   Detrick, Barbara ^a   Blankenship, Lori J ^a   Patierno, Steven R ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; DNA POLYMERASE; GUANINE; OLIGONUCLEOTIDE;

ARTICLE; CASE REPORT; CELL CYCLE S PHASE; CHROMATIN; DNA ADDUCT; DNA CROSS LINKING; DNA REPAIR; DNA REPLICATION; DNA SYNTHESIS INHIBITION; DOSE RESPONSE; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL;

BASE SEQUENCE; CARCINOGENS, ENVIRONMENTAL; CELL CYCLE; CELL LINE; CHILD, PRESCHOOL; CHROMIUM; CROSS-LINKING REAGENTS; DNA; DNA DAMAGE; DNA PRIMERS; DNA-DIRECTED DNA POLYMERASE; FIBROBLASTS; HUMANS; KINETICS; LUNG; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; S PHASE;

EID: 0029987469     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.7.1511     Document Type: Article

References (40)

1. International Agency for Cancer Research (1990) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Chromium, Nickel, and Welding, IARC Scientific Publications, Lyon, France, vol. 49, pp. 1-214.
2. Langard, S. (1990) One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am. J. Ind. Med., 17, 189-215.
3. DeFlora, S., Bagnasco, M., Serra, D. and Zanacchi, P. (1990) Genotoxicity of chromium compounds. A review. Mutat. Res., 238, 99-172.
4. Xu, J., Manning, F.C.R. and Patierno, S.R. (1994) Preferential formation and repair of chromium-induced DNA damage in nuclear matrix DNA. Carcinogenesis, 15, 1443-1450.
5. Manning, F.C.R., Xu, J. and Patierno, S.R. (1992) Transcription inhibition by carcinogenic chromate: relationship to DNA damage. Mol. Carcinogenesis, 6, 270-279.
6. Bridgewater, L.C., Manning, F.C.R. and Patierno, S.R. (1994) DNA polymerase arrest by adducted trivalent chromium. Mol. Carcinogenesis, 9, 122-133.
7. Bridgewater, L.C. Manning, F.C.R. and Patierno, S.R. (1994) Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA intrastrand cross-links. Carcinogenesis, 15, 2421-2427.
8. Standeven, A.M. and Wetterhahn, K.E. (1989) Chromium(VI) toxicity: uptake, reduction, and DNA damage. J. Am. Cell. Toxicol., 8, 1275-1283.
9. Klein, C.B., Frenkel, K. and Costa, M. (1991) The role of oxidative processes in metal carcinogenicity. Chem. Res. Toxicol., 4, 592-603.
10. Kasprzak, K.S. (1991) The role of oxidative damage in metal carcinogenicity. Chem. Res. Toxicol., 4, 604-615.
11. Standeven, A.M. and Wetterhahn, K.E. (1991) Is there a role for reactive oxygen species in the mechanism of chromium(VI) Carcinogenesis. Chem. Res. Toxicol., 4, 616-625.
12. Standeven, A.M. and Wetterhahn, K.E. (1991) Ascorbate is the principle reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis, 13, 1319-1324.
13. Wise, J.P., Leonard, J.C. and Patierno, S.R. (1991) Clastogenicity of lead chromate particles in hamster and human cells. Mutat. Res., 278, 69-79.
14. Bubley, G.J., Ogata, G.K., Dupuis, N.P. and Teicher, B.A. (1994) Detection of sequence-specific antitumor alkylating agent DNA damage from cells treated within culture and from a patient. Cancer Res., 54, 6325-6329.
15. Bubley, G.J., Teicher, B.A., Ogata, G.K., Sandoval, L.S. and Kusumoto, T. (1994) Differences in in vivo and in vitro sequence-specific sites of cisplatin-DNA addict formation and detection of a dose-response relationship. Biochem. Pharmacol., 48, 145-153.
16. Choo, K.H., Vissel, B., Nagy, A., Earle, E. and Kalitis, P. (1992) A survey of the genomic distribution of alpha satellite DNA on all human chromosomes, and derivation of a new consensus sequence. Nucleic Acids Res., 19, 1179-1183.
17. Baldini, A., Smith, D., Rocchi, M., Miller, O.J. and Miller, D.A. (1989) A human alphoid DNA clone from the EcoRI dimeric family. Genomics, 5, 822-828.
18. Vos, J.M. and Hanawalt, P.C. (1987) Processing of psoralen adducts in an active human gene: Repair and replication of DNA containing monoadducts and interstrand cross-links. Cell, 50, 789-799.
19. Xu, J., Wise, J.P. and Patierno, S.R. (1992) DNA damage induced by carcinogenic lead chromate particles in cultured mammalian cells. Mutat. Res., 280, 129-136.
20. Razin, S.V., Kekelidze, M.G., Lukanidine, E.M., Scherrer, K. and Georgiev, G.P. (1986) Replication origins attached to the nuclear skeleton. Nucleic Acids Res., 14, 8189-8207.
21. Ciejek, E.M., Tsai, M-J. and O'Malley, B.W. (1983) Actively transcribed genes are associated with the nuclear matrix. Nature (Lond.), 306, 607-609.
22. Morse, R.H. (1992) Transcribed chromatin. Trends Biol. Sci., 17, 23-26.
23. Reeves, R. (1984) Transcriptionally active chromatin. Biochem. Biophys. Acta, 782, 343-393.
24. Bridgewater, L.C., Manning, F.C.R. and Patierno, S.R. (1995) Chromium-mediated DNA interstrand cross-links cause base-specific DNA polymerase arrest. Am. Assoc. Cancer Res. Proc., 36, 850.
25. Tamino, G., Peretta, L. and Levis, A.G. (1981) Effects of trivalent and hexavalent chromium on the physicochemical properties of mammalian cell nucleic acids and synthetic polynucleotides. Chem. -Biol. Interactions, 37, 309-319.
26. Tsapakos, M.J. and Wetterhahn, K.E. (1983) The interaction of chromium with nucleic acids. Chem. -Biol. Interactions, 46, 265-277.
27. DeFlora, S., Bagnasco, M., Serra, D. and Zanacchi, P. (1990) Genotoxicity of chromium compounds. A review. Mutat. Res., 238, 99-172.
28. DeFlora, S. and Wetterhahn, K.E. (1989) Mechanisms of chromium metabolism and genotoxicity. Life Chem. Rep., 7, 169-244.
29. Hamilton, J.W. and Wetterhahn, K.E. (1986) Chromium(VI)-induced DNA damage in chick embryo liver and blood cells in vivo. Carcinogenesis, 7, 2085-2088.
30. Cupo, D.Y. and Wetterhahn, K.E. (1984) Repair of chromate-induced DNA damage in chick embryo hepatocytes. Carcinogenesis, 5, 1705-1708.
31. 4 in synchronous and asynchronous cultured mammalian cells. Mol. Pharmacol., 29, 606-613.
32. Costa, M., Zhitkovich, A. and Toniolo, P. (1993) DNA-protein cross-links in Welder: Molecular implications. Cancer Res., 53, 460-463.
33. Zhitkovich, A., Voitkun, V. and Costa, M. (1992) Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis, 16, 907-913.
34. Hamilton, J.W. and Wetterhahn, K.E. (1989) Differential effects of chromium(VI) in constitutive and inducible gene expression in chick embryo liver in vivo and correlation with chromium(VI)-induced DNA damage. Mol. Carcinogenesis., 2, 274-286.
35. Patierno, S.R., Bahn, D. and Landolph, J.R. (1988) Transformation of C3H/ 10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res., 48, 5280-5288.
36. Patierno, S.R., Blankenship, L.J., Wise, J.P., Xu, J., Bridgewater, L.C. and Manning, F.C.R. (1994) Genotoxin-induced apoptosis: Implications for carcinogenesis. In Hu, V.W. (ed.), The Cell Cycle: Regulators, Targets, and Clinical Applications. Plenum Press, New York, pp. 331-340.
37. Yang, J.L., Hsieh, Y.C., Wu, C.W. and Lee., T.C., (1992) Mutational specificity of chromium(VI) compounds at the hprt locus in Chinese hamster ovary-K1 cells. Carcinogenesis, 13, 2503-2508.
38. Stewart, B.W. (1994) Mechanisms of apoptosis: integration of genetic, biochemical and cellular indicators. J. Natl Cancer Inst., 86, 1286-1296.
39. Corcoran, G.B., Fix, L., Jones, D.P., Moslen, M.T., Nicotera, P., Oberhammer, F.A. and Buttyan, R. (1994) Apoptosis: Molecular control point in toxicity. Toxicol. Appl. Pharmacol., 128, 169-181.
40. Blankenship, L.J., Manning, F.C.R., Orenstein, J.M. and Patierno, S.R. (1994) Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol. Appl. Pharmacol., 126, 75-83.